Clinical Trial Update: Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) [NA]

View source ↗

Summary

This clinical trial assesses the safety and efficacy of the Surpass Elite with GUARDian Flow Diverter for treating intracranial aneurysms, and the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Surpass Elite with GUARDian Flow Diverter (GUARD)

Snippet

Sponsor: Stryker Neurovascular | Conditions: Aneurysm, Aneurysm, Intracranial | NA | Status: RECRUITING